A review of the role of antibiotic policies in the control of antibiotic resistance

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 4, 1999, Pages 459-465

  Gould, I M ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; COST CONTROL; CROSS INFECTION; DRUG COST; INTEGRON; MATHEMATICAL MODEL; MULTIDRUG RESISTANCE; POLICY; PRESCRIPTION; REVIEW; TRANSPOSON;

EID: 0032940946     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.4.459     Document Type: Review

References (59)

1. Shales, D. M., Gerding, D. N., John, J. F., Craig, W. A., Bornstein, D. L., Duncan, R. A. et al. (1997). Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infection Control and Hospital Epidemiology 18, 275-91.
2. Swartz, M. N. (1997). Use of antimicrobial agents and drug resistance. New England Journal of Medicine 337, 491-2.
3. Kunin, C. M. (1997). Antibiotic armageddon. Clinical Infectious Diseases 25, 240-1.
4. Gould, I. M., Hampson, J., Taylor, E. W. & Wood, M. J. (1994). Hospital antibiotic control measures in the UK. Journal of Antimicrobial Chemotherapy 34, 21-42.
5. Dunagan, W. C. & Medoff, G. (1993). Formulary control of antimicrobial usage. What price freedom? Diagnostic Microbiology and Infectious Disease 16, 265-74.
6. White, A. C., Atmar, R. L, Wilson, J., Cate, T. R., Stager, C. E. & Greenberg, S. B. (1997). Effects of requiring prior authorization for selected antimicrobials; expenditures, susceptibilities and clinical outcomes. Clinical Infectious Diseases 25, 230-9.
7. Goldmann, D. A. & Huskins, W. C. (1997). Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide. Clinical Infectious Diseases 24, Suppl. 1, S139-45.
8. Burke, J. P. & Pestotnik, S. L. (1996). Breaking the chain of antibiotic resistance. Current Opinion in Infectious Diseases, 9, 253-5.
9. McGowan, J. E. & Tenover, F. C. (1997). Control of antimicrobial resistance in the health care system. Infectious Disease Clinics of North America 11, 297-311.
10. McGowan, J. E. (1994). Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infection Control and Hospital Epidemiology 7, 478-83.
11. Acar, J. (1996). Antibiotic-resistant bacteria may outweigh their susceptible homologs. Clinical Microbiology and Infection 2, 78-9.
12. Ridley, M., Lynn, R., Barrie, D. & Stead, K. C. (1970). Antibiotic-resistant Staphylococcus aureus and hospital antibiotic policies. Lancet 230-3.
13. Barber, M., Dutton, A. A. C., Beard, M. A., Elmes, P. C. & Williams, R. (1960). Reversal of antibiotic resistance in hospital staphylococcal infection. British Medical Journal 1, 11-7.
14. Bulger, R. J. & Sherris, J. C. (1968). Decreased incidence of antibiotic resistance among Staphylococcus aureus. A study in a university hospital over a nine year period. Annals of Internal Medicine 69, 1099-108.
15. Price, D. J. E. & Sleigh, J. D. (1970). Control of infection due to Klebsiella aerogenes in a neuro-surgical unit by withdrawal of all antibiotics. Lancet ii, 1213-5.
16. Shulman, J. A., Terry, P. M. & Hough, C. E. (1971). Colonization with gentamicin resistant Pseudomonas aeruginosa, pyocine type 5, in a burn unit. Journal of Infectious Diseases 124, 18-23.
17. Fujita, K., Murono, K., Yoshikawa, M. & Murai, T. (1994). Decline of erythromycin resistance of group A streptococci in Japan. Pediatric Infectious Disease Journal 13, 1075-8.
18. Nowak, R. (1994). Hungary sees an improvement in penicillin resistance. Science 264, 364.
19. Seppala, H., Klaukka, T., Vuopio-Varkila, J., Muotiala, A., Helenius, H., Lager, K. et al. (1997). The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. New England Journal of Medicine 7, 441-6.
20. Arason, V. A., Kristinsson, K. G., Sigurdsson, J. A., Stefànsdóttir, G., Mölstad, S. & Gudmundsson, S. (1996). Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. British Medical Journal 313, 387-91.
21. Ballow, C. H. & Schentag, J. J. (1992). Trends in antibiotic utilization and bacterial resistance. Diagnostic Microbiology and Infectious Disease 15, Suppl., 27S-42S.
22. Hobson, R. P., MacKenzie, F. M. & Gould, I. M. (1996). An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland. Journal of Hospital Infection 33, 249-62.
23. Meyer, K. S., Urban, C., Eagan, J. A., Berger, B. J. & Rahal, J. J. (1993). Nosocomial outbreak of Klebsiella infection resistant to late generation cephalosporins. Annals of Internal Medicine 119, 353-8.
24. Rahal, J. J., Urban, C., Horn, D., Freeman, K., Segal-Maurer, S., Maurer, J. et al. (1998). Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. Journal of the American Medical Association, 280, 1233-7.
25. McNulty, C., Logan, M., Donald, I. P., Ennis, D., Taylor, D., Baldwin, R. N. et al. (1997). Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. Journal of Antimicrobial Chemotherapy 40, 707-11.
26. Voss, A., Milatovic, D., Wallrauch-Schwarz, C., Rosdahl, V. T. & Braveny, I. (1994). Methicillin-resistant Staphylococcus aureus in Europe. European Journal of Clinical Microbiology and Infectious Diseases 13, 50-5.
27. Bergogne-Bérézin, E. (1997). Interactions among antibiotics, bacteria and the human immune system: the clinical relevance of in vitro testing. Journal of Chemotherapy 9, 109-15.
28. Kernodle, D. S., Barg, N. L. & Kaiser, A. B. (1988). Low-level colonisation of hospitalised patients with methicillin-resistant coagulase-negative staphylococci and emergence of the organisms during surgical antimicrobial prophylaxis. Antimicrobial Agents and Chemotherapy 32, 202-8.
29. Hawkey, P. M. (1997). Quinolones in sweat and quinolone resistance. Lancet 349, 148-9.
30. Tenover, F. C. & McGowan, J. E. (1996). Reasons for the emergence of antibiotic resistance. American Journal of the Medical Sciences 9, 311-6.
31. Taylor, M. E. & Oppenheim, B. A. (1991). Selective decontamination of the gastrointestinal tract as an infection control measure. Journal of Hospital Infection 17, 271-8.
32. Lenski, R. E., Simpson, S. C. & Nguyen, T. T. (1994). Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness. Journal of Bacteriology 176, 3140-7.
33. Schrag, S. J., Perrot, V. & Levin, B. R. (1997). Adaption to the fitness costs of antibiotic resistance in Escherichia coli. Proceedings of the Royal Society of London, Series B 264, 1287-91.
34. Gould, I. M., Milne, K., Harvey, G. & Jason, C. (1991). Ionic binding, adaptive resistance and post-antibiotic effect of netilmicin and ciprofloxacin. Journal of Antimicrobial Chemotherapy 27, 741-8.
35. Riesenfeld, C., Everett, M., Piddock, L. J. V. & Hall, B. G. (1997). Adaptive mutations produce resistance to ciprofloxacin. Antimicrobial Agents and Chemotherapy 41, 2059-60.
36. Amyes, S. G. B. & Gould, I. M. (1984). Trimethoprim resistance plasmids. Annales de Microbiologie 135B, 177-86.
37. Chiew, Y. F., Yeo, S. F., Hall, L. M. C. & Livermore, D. M. (1998). Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomyin versus Enterobacteriaceae. Journal of Antimicrobial Chemotherapy 41, 247-51.
38. Gould, I. M. (1994). Risk factors for acquisition of multiply drug-resistant Gram-negative bacteria. European Journal of Clinical Microbiology and Infectious Diseases 13, Suppl 1, S30-8.
39. White, R. L., Friedrich, L. V., Mihm, L. B. & Bosso, A. (1997). Evaluation of changes in susceptibility of Gram-negative aerobes: pitfalls in examining only single drug relationships. In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, 1997. Abstract C-26, p. 50. American Society for Microbiology, Washington, DC.
40. Lipsitch, M. & Levin, B. R. (1997). The population dynamics of antimicrobial chemotherapy. Antimicrobial Agents and Chemotherapy 41, 363-73.
41. Katzenstein, D. (1997). Combination therapies for HIV infection and genomic drug resistance. Lancet 350, 970-1.
42. Mitchison, D. A. (1979). Basic mechanisms of chemotherapy. Chest 76, Suppl., 771-81.
43. Levy, S. B. (1994). Balancing the drug-resistance equation. Trends in Microbiology 2, 341-2.
44. Archibald, L., Phillips, L., Monnet, D., McGowan, J. E., Tenover, F. & Gaynes, R. (1997). Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clinical Infectious Diseases 24, 211-5.
45. Betts, R. F., Valenti, W. M., Chapman, S. W., Chonmaitree, T., Mowrer, G. & Pincus, P. (1984). Five year surveillance of aminoglycoside usage in a university hospital. Annals of Internal Medicine 100, 219-22.
46. Gerding, D. N., Larson, T. A., Hughes, R. A., Weiler, M., Shanholtzer, C. & Peterson, L. R. (1991). Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrobial Agents and Chemotherapy 35, 1284-90.
47. Berk, S. L., Alvarez, S., Ortega, G., Verghese, A. & Holtsclaw-Berk, S. A. (1986). Clinical and microbiologic consequences of amikacin use during a 42 month period. Archives of Internal Medicine 146, 538-41.
48. Young, E. J , Sewell, C. M., Koza, M. A. & Clarridge, J. E. (1985). Antibiotic resistance patterns during aminoglycoside restriction. American Journal of the Medical Sciences 290, 223-7.
49. King, J. W., White, M. C., Todd, J. R. & Conrad, S. A. (1992). Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside. Clinical Infectious Diseases 14, 908-15.
50. van landuyt, H. W., Boelaert, J., Glibert, B., Gordts, B. & Verbruggen, A. M. (1986). Surveillance of aminoglycoside resistance: European data. American Journal of Medicine 80, Suppl. 66, 76-81.
51. Moody, M. M., de Jongh, C. A., Schimpff, S. C. & Tillman, G. L. (1982). Long-term amikacin use. Effects on aminoglycoside susceptibility patterns of gram-negative bacilli. Journal of the American Medical Association 248, 1199-202.
52. Aubry-Damon, H., Legrand, P., Brun-Buisson, C., Astier, A., Soussy, C.-J. & Leclercq, R. (1997). Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: roles of an infection control program and changes in aminoglycoside use. Clinical Infectious Diseases 25, 647-53.
53. Gueudet, P., Gazagne, L., Lecaillon, E., Le Coustumier, A. & Bismuth, R. (1997). Emergence of new gentamicin sensitive strains and important decrease in associated resistances in French methicillin resistant Staphylococcus aureus. In Program and Abstracts of the Thirty-seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, 1997. Abstract 122, p. 135. American Society for Microbiology, Washington, DC.
54. Carr, J. R., Fitzpatrick, P. E., Cumbo, T. J. & Schentag, J. J. (1996). A reduction in oral vancomycin use and a concomitant reduction in vancomycin resistant enterococcus (VRE). Sixth Annual Meeting of the Society for Healthcare Epidemiology of America (SHEA), Abstract 59. Infection Control and Hospital Epidemiology 17, Suppl., 25.
55. Wright, W. L., Reynolds, T. M., Wells, V. D., Limon, L & Edmond, M. B. (1996). The impact of vancomycin restriction on infections due to vancomycin-resistant enterococci. Sixth Annual Meeting of the Society for Healthcare Epidemiology of America (SHEA), Abstract 60. Infection Control and Hospital Epidemiology 17, Suppl., 26.
56. Roghmann, M. C., Perdue, B. E. & Polish, L. (1997). Evaluation of a vancomycin (V) control program in response to a high prevalence of vancomycin resistant enterococcus (VRE) in a University hospital. In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy Toronto, 1997. Abstract J-82, p. 303. American Society for Microbiology, Washington, DC.
57. Antoniadou, A., Giamarellou, H., Avlami, A. & Sarmi, E. (1997). Restriction policy and strict monitoring of quinolones usage may decrease resistance in the hospital. In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, 1997. Abstract E-11, p. 115. American Society for Microbiology, Washington, DC.
58. Price, J., Ekleberry, A., Johnson, M., Melendy, M., Villalba, M. & Zervos, M. J. (1997). Evaluation of clinical practice guidelines on infection outcome and antibiotic resistance in an intensive care unit. In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, 1997. Abstract J-131, p. 312. American Society for Microbiology, Washington, DC.
59. Frank, M. O., Sorensen, S. J., Carr, J. A., McComb, J. S. & Harstein, A. I. (1996). Decrease in selected nosocomial infections following implementation of an antimicrobial prescribing improvement program. Sixth Annual Meeting of the Society of Healthcare Epidemiology in America (SHEA), Abstract S55. Infection Control and Hospital Epidemiology 17, Suppl., 36.